podar

Prune (Dried Plum)

1. Identity, Botanical Classification, and Natural Source

Prune is the common name for the dried fruit of select cultivars of the European plum, Prunus domestica L., a member of the flowering plant family Rosaceae. Prunes are dried European plums, and the plant carries the botanical name Prunus domestica, belonging to the family Rosaceae. The genus Prunus is broad: there are over 40 species of plum, the most common being Prunus domestica and Prunus salicina; dried plums are called prunes. A key taxonomic clarification is that not every variety of plum can be dried into a prune. Not all types of plums can be converted into prunes, and the same technique of drying cannot be attributed to all fruits from the same species; a majority of prune cultivars are freestone types, meaning the pit is easy to remove. More precisely, plums with high sugar content and firm flesh, dried without removal of the stone, are called prunes.

The origin of the plant is ancient and well-established: prunes are the dried fruits of some cultivars of Prunus domestica L. that originated from the Caucasus region in Western Asia. The variety dominant in commercial production today is the La Petite d'Agen. The popular La Petite d'Agen plum, originally from France, is the primary variety used in the United States after being introduced in the 19th century. More specifically, in 1856, Frenchman Louis Pellier introduced the La Petite d'Agen prune, a native of southwest France, to the Santa Clara Valley of California.

In scientific literature, the nomenclature can be a source of confusion. There are instances in the literature where authors refer to "prunes" when they mean fresh plums of unknown species and variety, probably because of the incorrect translation of the Latin name for the genus Prunus into English, a usage that is often the case for the Japanese oriental plum (Prunus salicina Lindl.). Furthermore, Chinese, Japanese, and Korean authors also use terms "prune" or "plum" interchangeably for the ume plum (Prunus mume), which is genetically distinct.

Common Forms and Preparations

The prune enters commerce and research in several forms. Processed forms include dried prunes, prune juice, prune juice concentrate, canned prunes, plum juice, plum paste, prune powder, prune fibre, low-moisture prune granules, low-moisture prune bits, jams, and jellies. Today, modern dehydrators have replaced the old methods of sun-drying prunes in the United States. Prune juice is produced by extracting and concentrating the liquid from the dried fruit and retains many, though not all, of the fiber components found in whole prunes.

2. Historical and Traditional Use

The practice of drying plums has roots in ancient civilization. Dried prunes are essentially dried plums of the European plum variety (Prunus domestica); the practice of drying plums dates back centuries, with evidence suggesting it was common in ancient civilizations for preservation and ease of transport. Originating near the Caucasus Mountains and Caspian Sea in Western Asia, plums were carried throughout Europe; they were brought by Louis Pellier to the United States in 1856 when he came to capitalize off of the Gold Rush, and instead found himself much more successful at cultivating plums.

Across multiple traditional medical systems, prunes and plums were recognized primarily for their digestive properties. In traditional medicine, prunes have long been recognized for their digestive benefits; they were commonly used as a natural remedy for constipation and to promote regularity, and in some cultures were also believed to have blood-purifying properties and were used to support liver function.

In Traditional Chinese Medicine (TCM), the plum held an established therapeutic role. According to traditional Chinese medicine, prunes are cooling to the system; they reverse stomach acidity and improve appetite by promoting digestion. The dried sour plum is used therapeutically in Chinese medicine to treat digestion problems, stomach flu, allergies, and parasites.

In Islamic and Prophetic Medicine, plums and prunes were discussed in classical texts. Prunes (or plums, referred to as "آلو") are discussed in the traditional Shi'i medical and hadith corpus and related works on Prophetic and Imamic advice on health. These references appear in early collections such as the Ṭibb al-A'immah, an early collection of the Imams' medical teachings that contains many short notes attributed to the Imams on foods and their properties, including plums and prunes.

In the context of Ayurveda, the classical tradition of India, the history is less direct. Though there is no mention of prunes in ancient Ayurvedic texts, modern-day practitioners of this ancient medicine attribute all the therapeutic properties of plums to this dried version.

Dried plums (Prunus domestica L.) have traditionally been recognized for their health benefits related to conditions such as constipation, irregular menstrual cycles, and mouth sores.

3. Key Constituents and Active Compounds

The nutritional and phytochemical composition of prunes is complex, and researchers attribute the observed health effects to synergistic interactions among multiple constituent classes rather than a single compound.

3.1 Macronutrients and Major Dietary Constituents

Dried plums contain significant amounts of sorbitol, quinic acid, chlorogenic acids, vitamin K1, boron, copper, and potassium. Dried plums are not only a source of dietary fiber, but also a good source of potassium and vitamin K; one serving of approximately four dried plums (92 kilocalories) provides 2.4 g of dietary fiber, 280 mg of potassium, and 22.8 µg of vitamin K.

Nutritionally, prunes are rich in vitamins A, B6, C, and K, as well as important minerals like iron, manganese, and potassium.

With respect to fiber specifically, prunes are high in fiber (6–7 g per 100 g), including cellulose and pectin, which act as bulking agents to increase stool output.

3.2 Sorbitol

Sorbitol is one of the most pharmacologically relevant constituents with respect to the laxative effect. Prunes contain 12 g of sorbitol per 100 g; sorbitol, a class of sugar alcohols, is poorly absorbed by the gut and acts as a laxative by increasing osmotic pressure in the intestinal lumen. Sorbitol is poorly absorbed in the small intestine, retains water osmotically, and is fermented in the colon to produce short-chain fatty acids (SCFAs), particularly butyrate, which enhances gut motility.

3.3 Phenolic Compounds (Chlorogenic Acids and Related Polyphenols)

Prunes are among the richest known food sources of phenolic compounds. Dried plums contain several dietary bioactives, including phenolic compounds such as 3-caffeoylquinic acid, 4-caffeoylquinic acid, 5-caffeoylquinic acid, 3-p-coumarolylquinic acid, caffeic acid, p-coumaric acid, and quercetin-3-O-rutinoside. The most prominent of these are the chlorogenic acids, which include both chlorogenic and neochlorogenic acid isomers. Prunes contain neochlorogenic and chlorogenic acids, two phenolic compounds that researchers believe contribute to faster gut transit.

Chlorogenic acid exhibits broad biological activity in preclinical models. Chlorogenic acid executes its anti-inflammatory function by moderating the synthesis and secretion of inflammatory mediators including TNF-α, IL-1β, IL-6, IL-8, NO, and PGE2; it also modulates key signaling pathways including NF-κB, MAPK, and Nrf2. Preclinical research has also noted that chlorogenic acid is known to exhibit potent antioxidant, antibacterial, and anti-inflammatory properties. It should be noted that these mechanistic findings derive largely from animal and in vitro models, and their direct relevance to the human consumption of prunes requires further clinical study.

3.4 Other Bioactive Compounds

Beyond the major classes above, prunes contain bioactive components such as polyphenolic compounds, antioxidants, and chlorogenic and neochlorogenic acids, as well as potassium, vitamin K, magnesium, and soluble fiber associated with improved cardiovascular health. The synergistic action of these and other compounds, which are also present in dried plums in less conspicuous amounts, may have beneficial health effects when dried plums are regularly consumed.

4. Mechanisms of Action

4.1 Gastrointestinal Laxative Mechanism

The laxative mechanism of prunes is considered to be multi-factorial. The mild laxative effects of plum can be attributed to the synergistic effect provided by dietary fibre, sorbitol, and polyphenols. Acting separately, the fiber components of cellulose and pectin act as bulking agents to increase stool output. Meanwhile, the consumption of sorbitol has a stool-softening effect in small doses, but can quickly change the fluid balance in the colon due to its osmotic effects in high doses. Prunes increase stool weight but not stool water, indicating that prunes increase stool bulk rather than stool water per se.

4.2 Bone Metabolism Mechanisms

The beneficial effects of dried plums on bone health may be in part due to the variety of phenolics present in the fruit; animal and cell studies suggest that dried plums and/or their extracts enhance bone formation and inhibit bone resorption through their actions on cell signaling pathways that influence osteoblast and osteoclast differentiation. At the systemic level, preclinical studies conducted in rodent models of osteopenia or osteoporosis show prune supplementation prevents and reverses bone loss by modulating oxidative and inflammatory pathways; inflammation and oxidative stress enhance bone resorption by increasing osteoclast function and suppress bone formation through reducing osteoblast function.

4.3 Gut Microbiota Modulation

Prune consumption appears to exert prebiotic-like effects on the gut. The polyphenols found in prunes also appear to act as prebiotics. Limited evidence suggests that prunes (along with raisins, cranberries, and dates) affect human gut microbiota composition in a potentially beneficial manner, in terms of effects on Bifidobacteria, Faecalibacterium prausnitzii, Lactobacillus, Ruminococcaceae, Klebsiella spp., and Prevotella spp. A trend toward increasing bifidobacteria has also been shown when consuming prunes for 4 weeks in an RCT, compared to control (P = 0.057).

5. Scientific Evidence by Area of Use

5.1 Constipation and Gastrointestinal Function

This is the most robustly studied and clinically supported area of prune research. Consuming dried plums, plum juice, or plum puree seems to improve constipation.

A landmark comparative trial tested whole prunes directly against psyllium, the standard over-the-counter fiber supplement. Despite both providing the same amount of fiber (6 g/day), prunes were more effective at increasing weekly complete spontaneous bowel movements (CSBMs) and improving stool consistency.

A 2022 randomized placebo-controlled trial (published in the American Journal of Gastroenterology) evaluated prune juice specifically. Prune juice containing sorbitol, pectin, and polyphenol ameliorated subjective complaints and hard feces while normalizing stool in chronic constipation in this randomized placebo-controlled trial.

A further RCT published in Clinical Nutrition examined the effect of prunes on stool output, gut transit time, and gastrointestinal microbiota. The effect of prunes on stool output, gut transit time, and gastrointestinal microbiota was examined in a randomised controlled trial published in Clinical Nutrition (2019).

A systematic review and meta-analysis of the available RCT data reached the following conclusion: a systematic review and meta-analysis identified two RCTs in people with chronic constipation that compared whole prune consumption to a psyllium supplement as an active control. Based on the totality of this evidence, a comprehensive review of over-the-counter therapies for chronic constipation assigned prunes a formal grade: there is moderate evidence (grade B recommendation) for fruit-based laxatives including prunes in the treatment of constipation. This is considered moderate-quality evidence; limitations include small sample sizes and variability in study designs across the available trials.

5.2 Bone Health and Osteoporosis

Bone health is the most intensively investigated long-term clinical outcome area for dried plum. To elucidate and summarize the potential mechanisms and effects of dried plums on bone health, a comprehensive review searched PubMed through January 2017 and identified twenty-four studies, including cell, animal, population, and clinical studies.

Early clinical evidence: In an initial 3-month randomized controlled trial, fifty-eight postmenopausal women not on hormone replacement therapy were randomly assigned to consume either 100 g dried plums or 75 g dried apples daily for 3 months; both regimens provided similar calories, fat, carbohydrate, and fiber. Only dried plums significantly increased serum levels of insulin-like growth factor-I (IGF-I) and bone-specific alkaline phosphatase (BSAP) activity — higher levels of both serum IGF-I and BSAP are associated with greater rates of bone formation.

One-year RCT: A subsequent and more definitive trial extended the duration to 12 months. A one-year clinical trial compared the effects of daily consumption of 100 g dried plum to 75 g dried apple on BMD and biomarkers of bone turnover in 100 osteopenic postmenopausal women; dried plum consumption significantly improved BMD of the ulna and lumbar spine compared with the dried apple control. Additionally, only dried plum significantly decreased serum levels of bone turnover markers including bone-specific alkaline phosphatase and tartrate-resistant acid phosphatase-5b; the findings confirmed the ability of dried plum to improve BMD in postmenopausal women, in part by suppressing the rate of bone turnover.

Long-term retention of benefit: A follow-up investigation assessed whether bone protection persisted after the intervention ended. A follow-up study demonstrated that postmenopausal women who previously consumed 100 g dried plum per day during the one-year clinical trial conducted five years earlier retained bone mineral density to a greater extent than those receiving the comparative control.

The Prune Study (Penn State): A large, well-designed RCT called The Prune Study was conducted at Pennsylvania State University. This ancillary investigation was a randomized controlled trial in which postmenopausal women were allocated to a no-prune control, 50 g/d prune, or 100 g/d prune group in a single-center, parallel-design, 12-month design.

Evidence in men: A study on the short-term effect of prunes in improving bone in men was published in Nutrients in 2022. Additionally, a study examined the effects of 12 months of consumption of 100 g dried plum (prunes) on bone biomarkers, density, and strength in men. These findings suggest the skeletal effects of prune consumption may not be limited to postmenopausal women.

Overall, the evidence for bone health is among the strongest in the prune literature, particularly in osteopenic postmenopausal women, supported by multiple RCTs using validated BMD endpoints. Limitations include small-to-moderate sample sizes and the fact that most trials come from a limited number of research groups.

5.3 Cardiometabolic Risk Factors

Cholesterol and lipid profiles: A randomized controlled trial examined cardiovascular markers in healthy older men. In a randomized controlled trial (NCT03408119), fifty-six men aged 55 to 80 years were placed into three groups — 100 g/day of prunes (n = 25), 50 g/day of prunes (n = 21), or a control (n = 10) — for 6 months; blood samples were analyzed for lipid concentrations including total cholesterol, LDL-c, VLDL-c, triglycerides, HDL-c, and the oxidative stress biomarker lipid hydroperoxide, as well as inflammatory biomarkers CRP and TNF-α.

The 12-month Prune Study at Penn State also evaluated glycemic outcomes: collectively, findings suggest that 12-month supplementation of prunes into the daily diet with a single serving (50 g/d) or two servings (100 g/d) did not impact markers of glycemic control and prevented adverse changes in central adiposity in postmenopausal women; the RCT observed no significant changes in fasting plasma glucose, insulin, and HOMA-IR after 12-month prune supplementation.

A broader review of dried fruit and cardiovascular outcomes acknowledged mixed results: there is little epidemiological evidence about the association of dried fruit consumption with cardiovascular disease incidence and mortality, as well as the risk of type 2 diabetes or obesity; clinical trial evidence for the effects of dried fruit consumption on cardiovascular risk factors, including glycaemic control, is mixed. Additional well-designed randomized controlled trials that account for the potential confounding effect of changes in energy intake and body weight are needed to confirm the cardiovascular benefits of dried fruit consumption.

In summary, the evidence for cardiovascular benefit from prune consumption is preliminary and mixed. Individual trials show promise in specific markers, but no large-scale or long-term RCT has established definitive cardiometabolic outcomes from prune supplementation.

5.4 Glycemic Response

Despite their high natural sugar content, prunes have a notably low glycemic index. Despite their sweet taste, dried plums do not cause a large postprandial rise in blood glucose and insulin. The glycemic index of prunes as measured in reference testing is low; according to Harvard Medical School reports, the glycemic index for one serving of prunes (60 grams, or about six prunes) is 29. The glycemic index of prunes is lower than that of fresh plums. The probable mechanism is that the soluble fiber content of prunes aids blood sugar regulation by slowing the rate at which food leaves the stomach. Formal clinical trial data from the Prune Study, however, found no significant glycemic benefit in an already healthy postmenopausal population over 12 months.

5.5 Inflammation and Immune Function

Secondary analyses from The Prune Study explored inflammatory outcomes. An analysis titled "Prune Consumption Attenuates Proinflammatory Cytokine Secretion and Alters Monocyte Activation in Postmenopausal Women" was reported as a secondary outcome analysis of the 12-month Prune Study RCT (Damani JJ et al., published in the Journal of Nutrition, 2024). This represents emerging, but early-stage, human evidence for anti-inflammatory effects.

5.6 Colon Cancer

Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer. The putative anti-cancer mechanisms center on the phenolic constituents. Preclinical (in vitro) studies on chlorogenic acid — a primary phenolic in prunes — have shown antiproliferative activity in colon cancer cell lines. However, these findings are limited to cell-culture and animal models. Further investigation of phenolic compounds in dried plums, particularly of high molecular weight polymers, their metabolism and biological actions, alone and in synergy with other dried plum constituents, is necessary to elucidate the observed health effects. There are currently no completed human clinical trials establishing that prune consumption reduces colon cancer risk.

6. Body Systems and Health Areas

• Gastrointestinal system: The most evidence-supported area. Prunes demonstrably improve stool frequency, stool consistency, and transit time in constipated adults. Prunes are a fiber-rich fruit that are effective in treating chronic constipation.
• Skeletal system: Accumulating evidence suggests that dried plum (Prunus domestica L.) is potentially an efficacious intervention for preventing and reversing bone mass and structural loss in an ovariectomized rat model of osteoporosis, as well as in osteopenic postmenopausal women.
• Cardiovascular system: Bioactive components such as polyphenolic compounds, antioxidants, chlorogenic and neochlorogenic acids, potassium, vitamin K, magnesium, and soluble fiber are associated with improved cardiovascular health, though clinical trial evidence for hard cardiovascular outcomes remains preliminary.
• Gut microbiota: The polyphenols in prunes appear to act as prebiotics, with limited human evidence suggesting favorable shifts in bifidobacteria.
• Metabolic/glycemic system: The low glycemic index of prunes is established by food science methodology; clinical trial evidence for glycemic improvement in populations at risk has not been confirmed.
• Immune and inflammatory system: Emerging human evidence from secondary trial analyses suggests modulation of proinflammatory cytokine secretion; these findings require replication in primary endpoint trials.

7. Dosage Forms and Reported Dosages

The following dosages are reported as used in the cited clinical studies only:

• Whole dried prunes, 100 g/day — used in a 3-month RCT (n=58 postmenopausal women) assessing bone biomarkers, compared to 75 g/day dried apple. Fifty-eight postmenopausal women were randomly assigned to consume either 100 g dried plums or 75 g dried apples daily for 3 months.
• Whole dried prunes, 100 g/day — used in the 1-year RCT (n=100 osteopenic postmenopausal women) comparing BMD outcomes to a dried apple control. The one-year clinical trial compared the effects of daily consumption of 100 g dried plum to 75 g dried apple in 100 osteopenic postmenopausal women.
• Whole dried prunes, 50 g/day and 100 g/day — both doses tested in The Prune Study (Penn State, NCT02822378), a 12-month parallel-design RCT in postmenopausal women evaluating bone density, cardiometabolic markers, and inflammation. The Prune Study allocated postmenopausal women to no-prune control, 50 g/d prune, or 100 g/d prune groups.
• Whole dried prunes, 50 g/day and 100 g/day — used in a 6-month RCT in men aged 55–80 evaluating cardiovascular markers. In a randomized controlled trial (NCT03408119), fifty-six men aged 55 to 80 years were placed into three groups: 100 g/day of prunes (n = 25), 50 g/day of prunes (n = 21), or a control (n = 10) for 6 months.
• Whole dried prunes, 50 g/day — used voluntarily by a case-report participant over 16 months following RCT completion, alongside calcium and vitamin D3 supplementation. Following study completion, the participant began consuming 50 g (approximately 6) dried plums daily, in addition to maintaining previously prescribed calcium/vitamin D3 supplements, for sixteen months after completing the RCT.

No official pharmacopeial or regulatory monograph dosage for prune as a medicinal/supplement product has been established by bodies such as the WHO, EMA, or U.S. Pharmacopeia at the time of this writing. The doses used in clinical trials range from 50 g to 100 g of whole dried prunes per day.

8. Safety Considerations and Interactions

8.1 Gastrointestinal Tolerability

Fruit-based laxatives including prunes receive a grade B (moderate evidence) recommendation for constipation; common adverse events reported across relevant trials include diarrhea, nausea, bloating, and abdominal pain, though no serious adverse events were reported. The sorbitol content is a key driver of these effects. The consumption of sorbitol has a stool-softening effect in small doses but can quickly change the fluid balance in the colon due to its osmotic effects in high doses.

8.2 Sugar Content and Glycemic Considerations

Prunes have a high natural sugar content per serving despite their low glycemic index. Despite their sweet taste, dried plums do not cause a large postprandial rise in blood glucose and insulin; however, portion size remains a relevant consideration given the energy density of the dried fruit. The 12-month Prune Study found that prune supplementation at 50 g/d and 100 g/d did not significantly worsen glycemic control in postmenopausal women, although one unadjusted analysis noted a small difference between the two dose groups that was lost after adjusting for body composition.

8.3 Oxalate Content and Kidney Stone Risk

The oxalate level in prunes is a relevant safety consideration; people with kidney issues might hesitate to eat prunes in high quantities since approximately 75–80% of kidney stones are calcium oxalate stones, and high oxalate intake can increase urinary oxalate excretion, raising stone risk. Additionally, small studies on the effects of ingestion of prunes (dried plums) have shown an acidifying effect on urine in humans, a finding whose clinical implications for stone formers have not been definitively established and require further study.

8.4 Vitamin K Content and Anticoagulant Interactions

Prunes are a notable dietary source of vitamin K1 (phylloquinone). Dried plums contain significant amounts of vitamin K1, and one serving of approximately four dried plums provides 22.8 µg of vitamin K. Because vitamin K plays a central role in the coagulation cascade, high or variable intake of vitamin K-rich foods can affect the activity of vitamin K antagonist anticoagulant drugs (such as warfarin), altering the international normalized ratio (INR) and requiring dosage adjustment. This is a well-established dietary interaction for any food with significant vitamin K content.

8.5 Long-Term Safety in Clinical Trials

The longest-duration clinical trials to date have run for 12 months. Within these time frames, no serious adverse events were reported in the relevant trials. Long-term safety data beyond one year from controlled settings are not available in the published literature reviewed here.

8.6 Evidence-Based Summary of Safety

While traditional uses such as blood purification and liver support are not always supported by rigorous scientific evidence, they reflect a historical understanding of prunes' potential health benefits. The overall safety profile of prune consumption at quantities studied in clinical trials (50–100 g/day of whole fruit) appears favorable, with adverse effects being primarily gastrointestinal and dose-dependent.

References

• Stacewicz-Sapuntzakis M. et al. — Dried Plums and Their Products: Composition and Health Effects (Critical Reviews in Food Science and Nutrition, 2001)
• Wallace TC — Dried Plums, Prunes and Bone Health: A Comprehensive Review (Nutrients, 2017) — PMC5409740
• Damani JJ et al. — Effects of Prune Supplementation on Cardiometabolic Health in Postmenopausal Women: Ancillary Analysis of a 12-Month RCT (PubMed 38490532)
• Damani JJ et al. — Effects of Prune Supplementation on Cardiometabolic Health in Postmenopausal Women (PMC11347804)
• Hooshmand S, Arjmandi BH — Bone-Protective Effects of Dried Plum in Postmenopausal Women: Efficacy and Possible Mechanisms (PMC5452226)
• Arjmandi BH et al. — Dried Plums Improve Indices of Bone Formation in Postmenopausal Women (PubMed 11860726)
• Hooshmand S et al. — Comparative Effects of Dried Plum and Dried Apple on Bone in Postmenopausal Women (PubMed 21736808)
• Hooshmand S et al. — Bone-Protective Effects of Dried Plum in Postmenopausal Women: Efficacy and Possible Mechanisms (PubMed 28505102)
• Hooshmand S, Arjmandi BH — Viewpoint: Dried Plum, an Emerging Functional Food That May Effectively Improve Bone Health (PubMed 19274852)
• Strock NC et al. — Dried Plum Consumption Improves Bone Mineral Density in Osteopenic Postmenopausal Woman: A Case Report (PMC8166764)
• De Souza MJ et al. — Rationale and Study Design of The Prune Study RCT (PMC9163423)
• PMC12766389 — Effects of Prune Consumption on the Incidence of Low Anterior Resection Syndrome: A Randomized Controlled Trial
• Dietary Management of Chronic Constipation: A Review of Evidence-Based Strategies (Proceedings of the Nutrition Society, Cambridge Core)
• Attaluri A et al. — Randomised Clinical Trial: Dried Plums (Prunes) vs. Psyllium for Constipation (ResearchGate)
• Rao SSC et al. — Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review (PMC8191753)
• Kern M et al. — Effects of Daily Prune Consumption on Cardiovascular Markers in Healthy Older Men — A Randomized Clinical Trial (Academia.edu)
• Putnik P et al. — Dried Fruits: Bioactives, Effects on Gut Microbiota, and Possible Health Benefits — An Update (PMC10097306)
• Yue W et al. — Chlorogenic Acid: A Review on Its Mechanisms of Anti-Inflammation, Disease Treatment, and Related Delivery Systems (PMC10534970)
• Ding Y et al. — Chlorogenic Acid Alleviates Colon Mucosal Damage Induced by a High-Fat Diet via Gut Microflora Adjustment (PMC7889347)
• Traditional Reports on Prunes and Modern Evidence: A Brief, Evidence-Based Note (Springer Nature Research Communities)
• ClinicalTrials.gov — Pilot Study on the Tolerability of Dietary Dried Plum (NCT01035372)
• EBSCO Research Starters — Prunes: Health and Medicine
• Prime Scholars — Plums: A Brief Introduction